QbTest, the computer task with motion tracking
Short answer
QbTest, made by Qbtech, is a clinic-based computer test of about 20 minutes: you respond to an on-screen task while a camera tracks your movement. It measures attention, impulsivity and activity against reference data. Qbtech and NICE both say it should be used only alongside a full clinical assessment, never as a diagnosis on its own.
Some clinics add a computer test to their ADHD assessments, and QbTest is one that NICE has reviewed in detail. It is worth knowing what it is and what it is not, especially if you are offered one or see it advertised.
What happens during a QbTest
Put simply, the task shows how you respond over time, and the camera adds information about how much you move while you do it. A clinician receives a report, not a verdict.
What NICE recommends
That age split is easy to miss. Qbtech markets the test for adults up to 60, but the NICE recommendation to use it in routine NHS practice applies to children and teenagers. For adults, NICE treats it as a research question for now.
Never on its own
Who gives it
QbTest uses Qbtech's own equipment and clinic accounts, and it is run in the clinic by healthcare staff. NICE also mentions a related web-based product from the same company, QbCheck, designed for remote testing, and lists it among technologies that need more research. If an online service offers you a computer test as proof of ADHD, that is a reason for caution, not confidence. A real QbTest result arrives as a report for your clinician, who reads it next to your interview, rating scales and history.
It is also fine to ask whether a QbTest is needed at all. Many evaluations reach a decision without one, and NICE guidance treats it as an option rather than a requirement
A task in the clinic versus questions at home
- The ASRS v1.1 screener is six questions you answer about your own experience. QbTest measures how you perform on a task in the moment.
- The screener is free online under its NYU license. QbTest needs clinic equipment and staff.
- The screener helps you decide whether to seek an evaluation. QbTest, when used, is part of the evaluation itself.
Self-report and task performance measure different things, and a person can look different on each. Neither replaces the history, interview and judgment of a clinician, and this page does not suggest that one is superior.
If you are offered a QbTest
- How will the clinician use the result alongside my interview and history?
- Is there anything about my day of testing, like poor sleep, nerves or illness, that I should mention?
A starting point for your next step.
Want a first step you can take at home? The free six-question ASRS v1.1 screener shows the official outcome immediately.Frequently asked questions
Can QbTest diagnose ADHD?
No. Qbtech, NICE and a 2024 systematic review all say it should be used only alongside a full clinical assessment, not as a diagnosis or screen on its own.
Is QbTest recommended for adults?
NICE recommends it as an option only for people aged 6 to 17. For adults 18 and over, NICE says more research is needed, although Qbtech markets it for ages 6 to 60.
Can I take QbTest at home?
QbTest is designed for clinic use with special equipment. Qbtech has a separate remote product, QbCheck, which NICE lists among technologies needing more research.
Sources
Source check: 2026-10-28. No medical review has occurred.
- Qbtech AB, "QbTest" product page, qbtech.com
- National Institute for Health and Care Excellence (NICE). Digital technologies for assessing attention deficit hyperactivity disorder (ADHD). HealthTech guidance HTG729 (formerly diagnostics guidance DG60). Published 21 October 2024.
- Bellato A, Hall CL, Groom MJ, Simonoff E, Thapar A, Hollis C, Cortese S. Practitioner Review: Clinical utility of the QbTest for the assessment and diagnosis of attention-deficit/hyperactivity disorder, a systematic review and meta-analysis. Journal of Child Psychology and Psychiatry. 2024;65(6):845-861.
Published 2026-10-28. Factual source check: ADHDFalcon editorial team, factual source check, 2026-10-28. No medical review has occurred.